Table 2. Clinical characteristics of patients and controls.
| Characteristics | IS Cases | Controls | P value |
|---|---|---|---|
| Number | 513 | 514 | – |
| Age | 62.26 ± 12.16 | 61.66 ± 13.49 | 0.452* |
| Gender (M/F) | 294/219 | 288/226 | 0.679† |
| BMI (kg/m2) | 24.83 ± 2.73 | 24.76 ± 2.83 | 0.677* |
| Glu (mmol/l) | 5.54 ± 3.46 | 4.55 ± 0.92 | <0.001* |
| TC (mmol/l) | 4.32 ± 1.05 | 3.65 ± 0.96 | <0.001* |
| TG (mmol/l) | 1.50 ± 0.92 | 1.06 ± 0.59 | <0.001* |
| HDL (mmol/l) | 1.25 ± 0.55 | 1.60 ± 0.38 | <0.001* |
| LDL (mmol/l) | 2.59 ± 0.87 | 1.99 ± 0.61 | <0.001* |
| Hypertension (%) | 211(41.13) | 115(22.37) | <0.001† |
| Diabetes (%) | 139(27.10) | 49(9.53) | <0.001† |
| Dyslipidemia (%) | 242(47.17) | 155(30.16) | <0.001† |
| Cardiopathy (%) | 46(8.97) | 10(1.95) | <0.001† |
| TOAST | |||
| Large atery atherosclerosis (%) | 119(23.20) | – | – |
| Cadio-embolic (%) | 27(5.26) | – | – |
| Small vessel disease (%) | 242(47.17) | – | – |
| Other determined causes (%) | 9(1.75) | – | – |
| Undetermined (%) | 116(22.61) | – | – |
*Student’s t-test; †Pearson’s χ2 test. Abbreviations: BMI, body mass index; F, female; Glu, glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; M, male; TC, total cholesterol; TG, triglyceride; TOAST, Trial of ORG 10172 in Acute Stroke Treatment.